Jun Wei

iRegene Therapeutics Co., Ltd.

Jun Wei is listed as iRegene Therapeutics Co., Ltd.. Jun is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 20 March 2027.

Compiled from published conference agendas; not yet confirmed by Jun. Is this you? Claim this profile.

About

Dr. Jun Wei is the Founder and CEO of iRegene Therapeutics, a clinical-stage biotechnology company developing a chemically defined, scalable, off-the-shelf iPSC-derived cell therapy platform for neurodegenerative and ophthalmic diseases. She has over 15 years of experience spanning stem cell biology, gene editing, regenerative medicine, and translational biotech commercialization across the UK and China. Her work bridges academic innovation, industrial platform development, and clinical-stage execution.

Upcoming

AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027

AD, PD AND LEWY BODY DISORDERS: NOVEL THERAPIES Speaker · 20 March 2027